Click here for slides on this topic


Glycemia

The presence of sugar in the blood. (See hyperglycemia, hypoglycemia.)


The following content matched the glossary term: Glycemia

NDEI.org Expert Commentary on ADA AGS Diabetes Treatment in Older Adults Report Silvio Inzucchi

Top

Expert commentary on American Diabetes Association (AD)/American Geriatrics Society (AGS) diabetes treatment in older adults report Silvio Inzucchi, MD.

American Diabetes Association (ADA)/American Geriatrics Society (AGS) Guidelines 2012

Top

Diabetes management guidelines for older adults from the American Diabetes Association (ADA)/American Geriatrics Society (AGS) 

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 11, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 11, 2012

ORIGIN trial results, insulin and cancer, TINSAL-T2D results, and more.

NDEI.org Expert Commentary Diabetes Monotherapy DURATION -4 Vivian Fonseca

Top

Expert commentary on diabetes monotherapy in DURATION-4 from Vivian Fonseca, MD

Bariatric surgery versus conventional medical therapy for type 2 diabetes

Top

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012 Mar 26. Roux-en-Y gastric bypass and biliopancreatic diversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remission.

Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes

Top

Hardman TC, Dubrey SW. Development and potential role of type 2 sodium glucose transporter inhibitors for management of type 2 diabetes. Diabetes Ther. 2011;2(3):133-145. There is a recognized need for new treatment options for type 2 diabetes mellitus (T2DM). Recovery of glucose from the glomerular filtrate represents an important mechanism in maintaining glucose homeostasis and represents a novel target for the management of T2DM.

From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy

Top

Dicembrini I, Pala L, Rotella CM. From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy. Exp Diabetes Res. 2011;2011:898913. Epub 2011 Jun 23. Promoting long-term adherence to lifestyle modification and choice of antidiabetic agent with low hypoglycemia risk profile and positive weight profile could be the most effective strategy in achieving sustained glycemic control and in reducing comorbidities.

Nontraditional markers of glycemia: associations with microvascular conditions(2)

Top

Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care. 2011;34(4):960-7. To compare the associations of nontraditional (fructosamine, glycated albumin, 1,5-anhydroglucitol [1,5-AG]) and standard (fasting glucose, HbA(1c)) glycemic markers with common microvascular conditions associated with diabetes mellitus.

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

Top

Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L; the Look AHEAD Research Group. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes. Diabetes Care. 2011;34(7):1481-1486. Overweight and obese individuals are encouraged to lose 5-10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.

Nontraditional markers of glycemia: associations with microvascular conditions

Top

Nontraditional markers of glycemia associations with microvascular conditionsSelvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW.Diabetes Care. 2011 Feb 18. Epub ahead of print   To compare the associations of nontraditional (fructosamine, glycated albumin, 1,5-anhydroglucitol [1,5-AG]) and standard (fasting glucose, glycated HbA(1c)) glycemic markers with common microvascular conditions associated with diabetes mellitus.

1 2 3 Next 

Slide Library Results

Search Results for: Glycemia Slides Found: 45
Effect of Phentermine on Weight Loss in Obese Patients With Type 1 or Type 2 Diabetes
WESDR: Hazard Ratios of Cause-Specific Mortality and Glycemia in Patients With Older-Onset Diabetes
Exenatide: Clinical Pharmacology
Exenatide: Effect on the Beta-Cell
Global Impact of Hyperglycemia: Ischemic Heart Disease and Stroke Mortality
Changing Glucose: Different Rates at Different Clinical Stages
RECORD: Study Design
RECORD: Effect of Rosiglitazone or Metformin Add-on to Sulfonylurea on A1C and FPG
RECORD: Effect of Rosiglitazone or Sulfonylurea Add-on to Metformin on A1C and FPG
Alogliptin Added to Metformin: A1C
12-Week Saxagliptin Improves Glycemic Control in Drug-Naïve Patients
Effect of Sitagliptin vs Rosiglitazone When Added to Metformin Monotherapy
ACCORD-MIND: Relationship Between Glycemia Status, Diabetes Duration, and Cognitive Test Scores
ACCORD-MIND: Relationship Between Glycemia Status, CVD, Stroke, Smoking Status, and Cognitive Test Scores
HEART2D: Primary Outcome Vs Days in Trial by Treatment Strategy
HEART2D Trial: A1C Values at Each Visit for 60 Months
Vildagliptin vs Metformin: A1C
Indian Diabetes Prevention Programme-2: Results
RECORD: Study Design
RECORD: CV Death and Hospitalization
RECORD: Time to Primary Endpoint
RECORD: Bone Fracture Rates in Upper and Distal Lower Limbs
RECORD: Conclusion
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Considerations for Glycemia, BP, and Dyslipidemia
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Background
Weight Gain from Type 2 Diabetes Treatment in ACCORD
Weight Gain in ACCORD By Type 2 Diabetes Treatment Allocation
Relationship Between Change in Weight and Change in A1C in ACCORD
ORIGIN-GRACE: Summary of Findings
ACCORD: Factors Associated with Increased Hypoglycemia Risk in Intensive and Standard Treatment Arms
Diabetes Surgery Study: Fewer Medications, Greater Weight Change with Gastric Bypass
Diabetes Surgery Study: Design
ADA Nutrition Guidelines: Energy Balance
Canola Oil Glycemia A1C Type 2 Diabetes | NDEI
Canola Oil Diet Study Glycemia A1C Type 2 Diabetes | NDEI
RECORD Rosiglitazone Cardiovascular Effects Slides | NDEI
A1C Testing ADA Type 1 Diabetes Guidelines | NDEI PPT
Noninsulin Therapies ADA Type 1 Diabetes Guidelines | NDEI Slides
Hypoglycemia Management ADA Type 1 Diabetes Guidelines | NDEI
Inpatient Glycemia Targets ADA Type 1 Diabetes Guidelines | NDEI PPT
Efficacy and Safety of Ranalozine on Glycemia in Type 2 Diabetes
Bariatric Surgery for Weight Loss in Type 2 Diabetes for CVD Prevention | NDEI
Frequency of A1C Testing for Diabetes Diagnosis ADA Guidelines | NDEI
Patient Selection Metabolic Surgery for Type 2 Diabetes Treatment Guidelines | NDEI
Metabolic Surgery Procedures for Treating Type 2 Diabetes Guidelines | NDEI